Chika Ohata

Summary

Country: Japan

Publications

  1. ncbi request reprint CD34-reactive myxoid dermal dendrocytoma
    Chika Ohata
    Department of Dermatology, Toyonaka Municipal Hospital, Osaka, Japan
    Am J Dermatopathol 24:50-3. 2002
  2. ncbi request reprint Lipomatous apocrine mixed tumor of the skin
    Chika Ohata
    Department of Dermatology, Higashiosaka City General Hospital, Osaka, Japan
    Am J Dermatopathol 25:138-41. 2003
  3. doi request reprint Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas
    Chika Ohata
    Department of Dermatology, Course of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    J Dermatol 35:215-21. 2008

Detail Information

Publications3

  1. ncbi request reprint CD34-reactive myxoid dermal dendrocytoma
    Chika Ohata
    Department of Dermatology, Toyonaka Municipal Hospital, Osaka, Japan
    Am J Dermatopathol 24:50-3. 2002
    ..Staining for vimentin and CD68 was positive. We believe this lesion to be a CD34-reactive myxoid dermal dendrocytoma of a type that has not been described previously...
  2. ncbi request reprint Lipomatous apocrine mixed tumor of the skin
    Chika Ohata
    Department of Dermatology, Higashiosaka City General Hospital, Osaka, Japan
    Am J Dermatopathol 25:138-41. 2003
    ..This case, in light of another recently reported case, indicates that adipose tissue can be the major mesenchymal element in apocrine mixed tumor of the skin...
  3. doi request reprint Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas
    Chika Ohata
    Department of Dermatology, Course of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
    J Dermatol 35:215-21. 2008
    ..Melanocytic nevi and malignant melanomas were negative for ERalpha, but both were positive for ERbeta. The ubiquitous expression of ERbeta may play a fundamental role in various normal skin cells and melanocytic tumors...